Panagora Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
CCM
DGI
Panagora Asset Management's MYGN Position: Q3 2022 in Review
Panagora Asset Management sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 205,382 shares — an estimated $3.73M sold.
Panagora Asset Management first reported a position in MYGN in Q2 2013 and held it in 19 quarters. The position peaked at $4.73M in Q3 2021. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.
- Panagora Asset Management reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
- Panagora Asset Management sold 205,382 Myriad Genetics shares in Q3 2022, an estimated $3.73M.
- Panagora Asset Management first reported a position in Myriad Genetics in Q2 2013 and held it in 19 quarters.
- Panagora Asset Management's Myriad Genetics position peaked at $4.73M in Q3 2021.
- 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.
Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.